SEC Comment Letter for ANAVEX LIFE SCIENCES CORP. (AVXL) (CIK 0001314052) (AVXL) — Aug 12, 2022

ANAVEX LIFE SCIENCES CORP. (AVXL) (CIK 0001314052)
Date: Aug. 12, 2022 · CIK: 0001314052 · Accession: 0000000000-22-008612

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-37606

Date

August 12, 2022

Author

Sandra Boenisch

Form

UPLOAD

Company

ANAVEX LIFE SCIENCES CORP. (AVXL) (CIK 0001314052)

Letter

United States securities and exchange commission logo August 12, 2022 Sandra Boenisch Principal Financial Officer ANAVEX LIFE SCIENCES CORP. 630 5th Avenue, 20th Floor New York , NY 10111 Re:ANAVEX LIFE SCIENCES CORP. 10-K filed November 24, 2021 File No. 001-37606 Dear Ms. Boenisch: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
August 12, 2022
Sandra Boenisch
Principal Financial Officer
ANAVEX LIFE SCIENCES CORP.
630 5th Avenue, 20th Floor
New York , NY 10111
Re:ANAVEX LIFE SCIENCES CORP.
10-K filed November 24, 2021
File No. 001-37606
Dear Ms. Boenisch:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io